Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07581548

Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery

Sponsor: Democritus University of Thrace

View on ClinicalTrials.gov

Summary

The primary objective of this study is the assessment of three tear substitute formulations in terms of postoperative discomfort following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.

Official title: Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery: A Non- Interventional, Observational Study

Key Details

Gender

All

Age Range

45 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

300

Start Date

2026-05-01

Completion Date

2027-05-01

Last Updated

2026-05-12

Healthy Volunteers

No

Conditions

Interventions

DRUG

Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)

Cataract patients will be administered Drops of Sodium Hyaluronate 0.15% and Dexpanthenol 2% quid in their postoperative regimen

DRUG

Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)

Cataract patients will be administered Drops of Sodium Hyaluronate 0.15% and Trehalose 3% quid in their postoperative regimen

DRUG

Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)

Cataract patients will be administered Drops of Sodium Hyaluronate 0.2% and Amino acids quid in their postoperative regimen

Locations (1)

University Hospital of Alexandroupolis

Alexandroupoli, Evros, Greece